Ocular Therapeutix Director Pravin Dugel Sells Shares

2026-03-06 09:02:20

Abstract generation in progress

Ocular Therapeutix Director Pravin Dugel sold 124,882 shares of the company’s common stock on February 12, 2026, for a total of $1,128,933. The sale was conducted to cover tax obligations related to restricted stock units. Following the transaction, Dugel retains significant direct and indirect ownership in the company.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.